A Novel Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth in Mouse Models of GI CancerJeremy B. Foote(University of Alabama at Birmingham), Gary A. Piazza(Auburn University)bioRxiv (Cold Spring Harbor Laboratory)May 19, 202310.1101/2023.05.17.541233Cited by 12SaveCiteExport RISWatch citationsRelated PapersNovel Non-Cyclooxygenase Inhibitory Derivative of Sulindac Inhibits Breast Cancer Cell Growth In Vitro and Reduces Mammary Tumorigenesis in Rats|Cancers|2023|10Assessment of KRASG12C inhibitors for colorectal cancer|Frontiers in Oncology|2024|9Variable Efficacy of the Non-covalent KRAS G12D Inhibitor (MRTX-1133) with Obesity in Murine Pancreatic Cancer|Research Square|2025|0